These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 32540170)

  • 41. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of Ranolazine in Patients With Chronic Angina in Patients With and Without Percutaneous Coronary Intervention for Acute Coronary Syndrome: Observations From the MERLIN-TIMI 36 Trial.
    Gutierrez JA; Karwatowska-Prokopczuk E; Murphy SA; Belardinelli L; Farzaneh-Far R; Walker G; Morrow DA; Scirica BM
    Clin Cardiol; 2015 Aug; 38(8):469-75. PubMed ID: 26059896
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
    Berger P
    JAMA; 2004 Jan; 291(3):365-7. PubMed ID: 14734600
    [No Abstract]   [Full Text] [Related]  

  • 44. Ranolazine for Treatment of Angina or Dyspnea in Hypertrophic Cardiomyopathy Patients (RHYME).
    Gentry JL; Mentz RJ; Hurdle M; Wang A
    J Am Coll Cardiol; 2016 Oct; 68(16):1815-1817. PubMed ID: 27737749
    [No Abstract]   [Full Text] [Related]  

  • 45. Medical therapy versus myocardial revascularization in chronic coronary syndrome and stable angina.
    Deedwania PC; Carbajal EV
    Am J Med; 2011 Aug; 124(8):681-8. PubMed ID: 21787900
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ranolazine in patients with angina and coronary artery disease.
    Scirica BM; Morrow DA
    Curr Cardiol Rep; 2007 Jul; 9(4):272-8. PubMed ID: 17601393
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmacological Management of Chronic Stable Angina: Focus on Ranolazine.
    Rosano GMC; Vitale C; Volterrani M
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):393-398. PubMed ID: 27417323
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Banerjee K; Ghosh RK; Kamatam S; Banerjee A; Gupta A
    Int J Cardiol; 2017 Jan; 227():556-564. PubMed ID: 27838121
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Metabolic efficiency with ranolazine for less ischemia in non-ST elevation acute coronary syndromes (MERLIN TIMI-36) study.
    Melloni C; Newby LK
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):9-16. PubMed ID: 18095903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
    Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Quality of Life Changes After Chronic Total Occlusion Angioplasty in Patients With Baseline Refractory Angina.
    Hirai T; Grantham JA; Sapontis J; Cohen DJ; Marso SP; Lombardi W; Karmpaliotis D; Moses J; Nicholson WJ; Pershad A; Wyman RM; Spaedy A; Cook S; Doshi P; Federici R; Nugent K; Gosch KL; Spertus JA; Salisbury AC
    Circ Cardiovasc Interv; 2019 Mar; 12(3):e007558. PubMed ID: 30871356
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Impact of Cell Therapy on Myocardial Perfusion and Cardiovascular Outcomes in Patients With Angina Refractory to Medical Therapy: A Systematic Review and Meta-Analysis.
    Khan AR; Farid TA; Pathan A; Tripathi A; Ghafghazi S; Wysoczynski M; Bolli R
    Circ Res; 2016 Mar; 118(6):984-93. PubMed ID: 26838794
    [TBL] [Abstract][Full Text] [Related]  

  • 53. At the dawn of a new era in treating angina pectoris, or just another antianginal drug? Some considerations about ranolazine.
    Bălan H
    Rom J Intern Med; 2010; 48(4):361-9. PubMed ID: 21528766
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetic drug-drug interaction study of ranolazine and metformin in subjects with type 2 diabetes mellitus.
    Zack J; Berg J; Juan A; Pannacciulli N; Allard M; Gottwald M; Zhang H; Shao Y; Ben-Yehuda O; Jochelson P
    Clin Pharmacol Drug Dev; 2015 Mar; 4(2):121-9. PubMed ID: 27128216
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Coronary Sinus Reducer Implantation for the Treatment of Chronic Refractory Angina: A Single-Center Experience.
    Giannini F; Baldetti L; Ponticelli F; Ruparelia N; Mitomo S; Latib A; Montorfano M; Jabbour RJ; Aurelio A; Ferri L; Mangieri A; Regazzoli D; Ancona M; Pagnesi M; Faccini A; Chieffo A; Azzalini L; Carlino M; Colombo A
    JACC Cardiovasc Interv; 2018 Apr; 11(8):784-792. PubMed ID: 29673511
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina.
    Allen KB; Dowling RD; Fudge TL; Schoettle GP; Selinger SL; Gangahar DM; Angell WW; Petracek MR; Shaar CJ; O'Neill WW
    N Engl J Med; 1999 Sep; 341(14):1029-36. PubMed ID: 10502592
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of Angina Pectoris Associated with Coronary Microvascular Dysfunction.
    Ong P; Athanasiadis A; Sechtem U
    Cardiovasc Drugs Ther; 2016 Aug; 30(4):351-356. PubMed ID: 27358172
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ranolazine: impact on quality of life in patients with stable angina pectoris, results from an observational study in Austria - the ARETHA AT study.
    Zweiker R; Aichinger J; Metzler B; Lang I; Wallner E; Delle-Karth G
    Wien Klin Wochenschr; 2019 Apr; 131(7-8):165-173. PubMed ID: 30963332
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
    Thadani U
    Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.
    Fanaroff AC; Prather K; Brucker A; Wojdyla D; Davidson-Ray L; Mark DB; Williams RB; Barefoot J; Weisz G; Ben-Yehuda O; Stone GW; Ohman EM; Alexander KP
    Am J Cardiol; 2019 May; 123(9):1399-1405. PubMed ID: 30771861
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.